| Dr Jithinraj Edakkanambeth Varayil, MD | |
|
1200 W State St, Rockford, IL 61102 | |
| (815) 490-1600 | |
| (815) 490-1881 |
| Full Name | Dr Jithinraj Edakkanambeth Varayil |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 15 Years |
| Location | 1200 W State St, Rockford, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033591847 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mayo Clinic Hospital Rochester | Rochester, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mayo Clinic | 6507778255 | 4232 |
News Archive
Researchers at Amgen are testing a fully human monoclonal antibody that inhibits the activity of insulin-like growth factors (IGF-1 and IGF-2) and appears to reduce pancreatic cancer cells in early testing, according to a report in Molecular Cancer Therapeutics, a journal of the American Association for Cancer Research.
For the first time, Mayo Clinic researchers and colleagues present data on how nervous system tumors, called neuroblastomas, spread. Their paper, published in Cancer Cell, clarifies the relationship between two genes that fuel the aggressive spread of neuroblastomas.
BioMarin Pharmaceutical Inc. announced today that Firdapse™ (3,4-diaminopyridine) is now commercially available in the European Union (E.U.) for the treatment of the rare autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS). Launching immediately in Germany and the UK, the company expects to subsequently launch Firdapse in all major European markets by the end of 2010.
The new wave of thinking effectively turns on its head the idea that healthcare innovation must always make something more high-tech, more sophisticated, more complex - and hence more expensive.
› Verified 9 days ago
| Entity Name | Mayo Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922074434 PECOS PAC ID: 6507778255 Enrollment ID: O20031103000285 |
News Archive
Researchers at Amgen are testing a fully human monoclonal antibody that inhibits the activity of insulin-like growth factors (IGF-1 and IGF-2) and appears to reduce pancreatic cancer cells in early testing, according to a report in Molecular Cancer Therapeutics, a journal of the American Association for Cancer Research.
For the first time, Mayo Clinic researchers and colleagues present data on how nervous system tumors, called neuroblastomas, spread. Their paper, published in Cancer Cell, clarifies the relationship between two genes that fuel the aggressive spread of neuroblastomas.
BioMarin Pharmaceutical Inc. announced today that Firdapse™ (3,4-diaminopyridine) is now commercially available in the European Union (E.U.) for the treatment of the rare autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS). Launching immediately in Germany and the UK, the company expects to subsequently launch Firdapse in all major European markets by the end of 2010.
The new wave of thinking effectively turns on its head the idea that healthcare innovation must always make something more high-tech, more sophisticated, more complex - and hence more expensive.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jithinraj Edakkanambeth Varayil, MD 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511 | Dr Jithinraj Edakkanambeth Varayil, MD 1200 W State St, Rockford, IL 61102 Ph: (815) 490-1600 |
News Archive
Researchers at Amgen are testing a fully human monoclonal antibody that inhibits the activity of insulin-like growth factors (IGF-1 and IGF-2) and appears to reduce pancreatic cancer cells in early testing, according to a report in Molecular Cancer Therapeutics, a journal of the American Association for Cancer Research.
For the first time, Mayo Clinic researchers and colleagues present data on how nervous system tumors, called neuroblastomas, spread. Their paper, published in Cancer Cell, clarifies the relationship between two genes that fuel the aggressive spread of neuroblastomas.
BioMarin Pharmaceutical Inc. announced today that Firdapse™ (3,4-diaminopyridine) is now commercially available in the European Union (E.U.) for the treatment of the rare autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS). Launching immediately in Germany and the UK, the company expects to subsequently launch Firdapse in all major European markets by the end of 2010.
The new wave of thinking effectively turns on its head the idea that healthcare innovation must always make something more high-tech, more sophisticated, more complex - and hence more expensive.
› Verified 9 days ago
Srivani Sridhar, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3505 N. Bell School Rd., Rockford, IL 61114 Phone: 779-696-0300 | |
Dr. John Wall, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1200 W State St, Rockford, IL 61102 Phone: 815-490-1600 | |
Dr. Steven J Lidvall, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1215 N Alpine Rd, Rockford, IL 61107 Phone: 815-391-7807 | |
Dr. Arpana Broor Mathur, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 698 Featherstone Rd, Suite 250, Rockford, IL 61107 Phone: 815-399-4404 Fax: 815-484-7091 | |
Ms. Rachael Mcpeek, NP Family Medicine Medicare: Medicare Enrolled Practice Location: 1215 N Alpine Rd, Rockford, IL 61107 Phone: 815-490-1600 | |
Dr. Raju M Shanmugam, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3401 N Perryville Rd, Rockford, IL 61114 Phone: 815-971-2000 Fax: 815-971-2000 |